Phesgo SC (perjeta and herceptin)
pCPA File Number:
21762
Negotiation Status:
Concluded without agreement
Indication(s):
Metastatic breast cancer (HER2-positive) first-line treatment
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: